Clinical Trial Update: Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and Parkinsonism [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating development of a novel imaging biomarker to differentiate Parkinson's disease from Parkinsonism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED